CDTX

Cidara Therapeutics
CDTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$296.23M
EV
$130.75M
Shares Outstanding
15.94M
Beta
0.80

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$42.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cidara Therapeutics, Inc.

gainify
CDTX

Cidara Therapeutics, Inc.

CDTX

Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the tr...

Sector

Healthcare

Industry

Biotechnology

CEO

Stein, Jeffrey

Employees

38

IPO Date

2015-04-15

Headquarters

6310 Nancy Ridge Drive, Suite 101, San Diego, California, 92121, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.